ICBio is a Contract Research Organization based in Bangalore, INDIA, engaged in conducting Bioequivalence / Bioavailability studies ( BA/ BE studies),
Pharmacokinetic / Pharmacodynamic studies, Clinical End Point studies, and clinical safety and
efficacy studies for Pharma, Biotech, Nutraeuticals, Herbals, Cosmetics and OTC
Product companies by strictly adhering to 21 CFR ICH GCP regulatory compliant systems and procedures. Our facility is approved by Drug Controller General
of India (DCGI), CDSCO, ISO 9001:2015, ISO 15189:2012 / NABL Accredited
Clinical Laboratory, Inspected and approved by Ministry of Health-Kazakhstan
and other relevant regulatory authority requirements. We conducted the BE studies to US FDA, DCGI, FDA Philippines, MoH Khazakhstan, Tanzania, Vietnam, Ukraine and many ROW country regulatories with no observations so far.
Our BA/BE facility has state of art facilities
like Clinical pharmacology unit with ICU Beds for conducting BA/BE studies with Access controlled areas...